| Authors: |
Liu CM; Department of Cardiometabolic Disorders, Amgen Research, Thousand Oaks, CA, USA.; Amgen R&D Postdoctoral Fellows Program, Amgen Inc., Thousand Oaks, CA, USA., Killion EA; Department of Cardiometabolic Disorders, Amgen Research, Thousand Oaks, CA, USA., Hammoud R; The Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, Toronto, Ontario, Canada., Lu SC; Department of Cardiometabolic Disorders, Amgen Research, Thousand Oaks, CA, USA., Komorowski R; Department of Cardiometabolic Disorders, Amgen Research, Thousand Oaks, CA, USA., Liu T; Center for Research Acceleration by Digital Innovation, Amgen Research, Thousand Oaks, CA, USA., Kanke M; Department of Research Technologies, Amgen Research, South San Francisco, CA, USA., Thomas VA; Department of Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, CA, USA., Cook K; Department of Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, CA, USA., Sivits GN Jr; Department of Cardiometabolic Disorders, Amgen Research, Thousand Oaks, CA, USA., Ben AB; Department of Cardiometabolic Disorders, Amgen Research, Thousand Oaks, CA, USA., Atangan LI; Department of Cardiometabolic Disorders, Amgen Research, Thousand Oaks, CA, USA., Hussien R; Department of Translational Safety and Bioanalytical Sciences, Amgen Research, South San Francisco, CA, USA., Tang A; Department of Translational Safety and Bioanalytical Sciences, Amgen Research, South San Francisco, CA, USA., Shkumatov A; Department of Translational Safety and Bioanalytical Sciences, Amgen Research, South San Francisco, CA, USA., Li CM; Department of Research Technologies, Amgen Research, South San Francisco, CA, USA., Drucker DJ; The Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, Toronto, Ontario, Canada., Véniant MM; Department of Cardiometabolic Disorders, Amgen Research, Thousand Oaks, CA, USA. mveniant@amgen.com. |
